Literature DB >> 7568367

Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy.

A Troisi1, E Vicario, F Nuccetelli, N Ciani, A Pasini.   

Abstract

Nineteen mentally retarded inpatients with epilepsy and a history of current or recent aggressive behavior were treated with 20 mg of fluoxetine daily. All were concurrently taking other psychotropic medications, including carbamazepine and neuroleptics. A standardized rating scale (MOAS) was used to assess the effects of fluoxetine on aggressive behavior. There were wide individual differences in drug response. In nine patients, fluoxetine treatment was associated with increased aggression, while drug withdrawal led to a decrease to below pretreatment levels. Two hypotheses concerning the apparent association between fluoxetine and increased aggression are discussed: 1) adverse effects secondary to either drug interaction or fluoxetine overmedication; and 2) a specific serotonergically mediated effect on the regulation of aggression. This study suggests that the clinician who treats mentally retarded patients with impulsive aggressive behavior should remain aware that fluoxetine may have diverse effects on aggression that vary over time and interindividually.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568367     DOI: 10.1055/s-2007-979593

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  6 in total

Review 1.  Behavioral and pharmacogenetics of aggressive behavior.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2010-09-03       Impact factor: 4.530

Review 3.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

Review 4.  Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities.

Authors:  R Antochi; C Stavrakaki; P C Emery
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

5.  Obsessive Compulsive Disorder with Intellectual Disability: A Diagnostic and Therapeutic Challenge.

Authors:  Priyanka Gautam; M S Bhatia
Journal:  J Clin Diagn Res       Date:  2015-09-01

6.  Management of psychotropic medications in adults with intellectual disability: a scoping review.

Authors:  Ashley Costello; Eithne Hudson; Susan Morrissey; Drona Sharma; Dervla Kelly; Owen Doody
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.